STOCK TITAN
  1. Home
  2. Sec-filings
  3. CL
  4. [Form 4] COLGATE PALMOLIVE CO Insider Trading Activity

Colgate-Palmolive (CL) director receives stock grant and 2,424-share option award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

COLGATE PALMOLIVE CO director Kimberly A. Nelson received new equity compensation awards. On May 11, 2026, she acquired 2,075 shares of Common Stock as an annual director stock grant under the issuer's incentive compensation plan, increasing her direct holdings to 11,634 shares.

On the same date, she also received a stock option for 2,424 shares of Common Stock with an exercise price of $86.74 per share, expiring on May 11, 2034. This option becomes exercisable in equal annual installments over three years, beginning on the first anniversary of the grant date. The filing also lists additional indirect holdings through a trust, spouse, and a family trust.

Positive

  • None.

Negative

  • None.
Insider Nelson Kimberly A
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 2,424 $0.00 --
Grant/Award Common Stock 2,075 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 2,424 shares (Direct, null); Common Stock — 11,634 shares (Direct, null); Common Stock — 575 shares (Indirect, By Family Trust)
Footnotes (1)
  1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan. Annual director stock option grant under the issuer's incentive compensation plan. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
Director stock grant 2,075 shares Annual director stock grant of Common Stock on May 11, 2026
Direct holdings after grant 11,634 shares Common Stock directly owned after the 2,075-share grant
Stock option size 2,424 options Stock Option (Right to Buy) for underlying Common Stock
Option exercise price $86.74 per share Conversion or exercise price of the stock option
Option expiration May 11, 2034 Expiration date of the 2,424-share stock option grant
Indirect trust holdings 1,799 shares Common Stock held indirectly by trust after the reported date
Annual director stock grant financial
"Annual director stock grant under the issuer's incentive compensation plan"
incentive compensation plan financial
"under the issuer's incentive compensation plan, credited to a stock unit account"
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
stock unit account financial
"credited to a stock unit account pursuant to the issuer's incentive compensation plan"
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
exercisable in equal annual installments financial
"Option becomes exercisable in equal annual installments over three years"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Nelson Kimberly A
(Last)(First)(Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
(Street)
NEW YORK NEW YORK 10022
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/11/2026A(1)2,075A$0.000011,634D
Common Stock575IBy Family Trust
Common Stock215IBy Spouse
Common Stock1,799IBy Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$86.7405/11/2026A(2)2,424 (3)05/11/2034Common Stock2,424$0.00002,424D
Explanation of Responses:
1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.
2. Annual director stock option grant under the issuer's incentive compensation plan.
3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
/s/ Kristine Hutchinson, Attorney-in-Fact05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Kimberly A. Nelson report in this Colgate-Palmolive (CL) Form 4?

Kimberly A. Nelson reported new equity awards from Colgate-Palmolive. She received 2,075 shares of Common Stock as an annual director stock grant and a stock option for 2,424 shares, both granted under the company’s incentive compensation plan.

How many Colgate-Palmolive (CL) shares did Kimberly A. Nelson receive in the stock grant?

She received 2,075 shares of Common Stock. This annual director stock grant was credited under Colgate-Palmolive’s incentive compensation plan and brought her directly held Common Stock position to 11,634 shares following the transaction.

What are the key terms of Kimberly A. Nelson’s new Colgate-Palmolive (CL) stock option?

The new option covers 2,424 shares at an exercise price of $86.74. It is a right to buy Common Stock, expires on May 11, 2034, and becomes exercisable in equal annual installments over three years starting on the first anniversary of the grant date.

How many Colgate-Palmolive (CL) shares does Kimberly A. Nelson hold after these awards?

She holds 11,634 shares of Common Stock directly after the grant. The Form 4 also lists indirect holdings of 1,799 shares by a trust, 215 shares by her spouse, and 575 shares by a family trust, all reported as indirect ownership.

Are Kimberly A. Nelson’s Colgate-Palmolive (CL) Form 4 transactions open-market buys or compensation awards?

The reported transactions are compensation-related awards, not open-market purchases. The filing classifies them as grants or awards under Colgate-Palmolive’s incentive compensation plan, including an annual director stock grant and an annual director stock option grant.

When do Kimberly A. Nelson’s new Colgate-Palmolive (CL) options become exercisable?

The options vest in three equal annual installments. According to the filing, they become exercisable in equal annual installments over three years, beginning on the first anniversary of the May 11, 2026 grant date, and expire on May 11, 2034.